Bavarian Nordic Rises As It Meets Demand For Monkeypox Vaccine

Shares Up 42% Following Unexplained Outbreaks

 
• By Andrew McConaghie
  
Bavarian Nordic
The company has 1.4 million finished vials of its monkeypox vaccine in reserve, which could help stem further spread of the virus. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip